Jacobs Levy Equity Management, Inc Innoviva, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $23.9 Billion
- Q3 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Innoviva, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 81,690 shares of INVA stock, worth $1.82 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
81,690
Previous 91,246
10.47%
Holding current value
$1.82 Million
Previous $1.83 Million
18.71%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding INVA
# of Institutions
282Shares Held
82.7MCall Options Held
13.2KPut Options Held
156K-
Black Rock Inc. New York, NY9.63MShares$214 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.1MShares$158 Million0.0% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$140 Million0.14% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.59MShares$102 Million0.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.33MShares$96.4 Million0.02% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.55B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...